Autoantibodies against MOG are reportedly found in patients with a spectrum of inflammatory demyelinating diseases of the CNS, including acute disseminated encephalomyelitis, multiple sclerosis, transverse myelitis, and neuromyelitis optica (NMO) [1]. The gene discussed is MOG; the disease is neuromyelitis optica.